Comparing two methods for treating atrial fibrillation
Official title: Lesion Formation With Pulsed Field Versus Cryobaloon Ablation as Assessed by Cardiac Magnetic Resoncance
Run by Hospital Clinic of Barcelona · NCT06220006 · Data updated 2026-11-12
This study is testing whether pulsed field ablation or cryoballoon ablation is a better way to treat atrial fibrillation in patients having this procedure for the first time.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 104 (estimated) |
| Sponsor | Hospital Clinic of Barcelona Academic / other |
| Locations | 1 site (Barcelona, Catalonia) |
| Status | Recruiting |
| Started | November 1, 2023 |
| Main results expected | November 1, 2025 |
| Study ends | November 1, 2026 |
| Registry record updated | April 7, 2026 |
| Trial ID | NCT06220006 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients scheduled for their first atrial fibrillation catheter ablation.
✕Probably not a fit
Patients with long-standing persistent atrial fibrillation or those who have had prior left atrial ablation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized study compares pulsed field ablation and cryoballoon ablation in patients undergoing first-time atrial fibrillation catheter ablation. The focus is on assessing the quality of ablation lesions using late gadolinium enhancement cardiac magnetic resonance imaging three months post-ablation. Patients will be assigned in a 2:1 ratio to receive either pulsed field ablation or cryoballoon ablation for pulmonary vein isolation. The study aims to evaluate the efficacy and safety of these two ablation techniques.
Why it matters
Potential benefit: If successful, this study could lead to improved outcomes and reduced complications for patients undergoing atrial fibrillation ablation.
How similar studies have gone: Previous studies have shown promising results for pulsed field ablation, indicating potential benefits over traditional methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients scheduled for first-time atrial fibrillation catheter ablation Exclusion Criteria: * age \<18 years * long-standing persistent atrial fibrillation * prior left atrial ablation * pregnancy or lactation * reduced left ventricular ejection fraction * GFR \<30% * BMI \>35% * left atrial diameter \>55 mm * cardiac implantable electronic device
Where it's running
-
Hospital Clinic, University of Barcelona
Barcelona, Catalonia, Spain Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities
This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.
-
Dual Energy ablation with SmartTouch SF catheter in persistent atrial fibrillation
This study tests a pulsed field and radiofrequency ablation system to treat persistent atrial fibrillation in adults who have not responded well to prior medications.
-
Identifying AF patients who may need more than standard ablation using Volta AF-Xplorer II
This trial tests whether AI-identified dispersion areas during AF ablation can predict recurrence after a standard pulmonary vein isolation in patients with persistent AF.
-
4D intracardiac echocardiography to guide left atrial appendage occlusion procedures
A new 4D ICE catheter is being tested alongside standard imaging to see if it can safely guide left atrial appendage occlusion procedures for adults with atrial fibrillation.
-
Thoracoscopic vs Catheter Ablation as the First Rhythm Control in Atrial Fibrillation with a Large Left Atrium
This trial tests whether thoracoscopic surgical ablation is better at keeping atrial fibrillation under control than catheter ablation in people with persistent AF and a large left atrium who have not had an ablation before.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.